173 related articles for article (PubMed ID: 7458980)
1. Clinical study of niceritrol on serum lipids in the treatment of hyperlipidemia.
Kibata M; Ishida M; Asano K; Uehara H; Saito K; Fuchimoto T; Ugaki K; Murakami H; Matoba K; Kotakemori Y; Shirai K; Yoshioka H; Nanba M; Yasuda M; Ishizaki M; Kitagawa N; Ikejiri K; Inohara R; Lee BJ; Saino S; Sakado J; Matuzaka H; Numata K; Mandai M; Miyake K; Nakamura K
Atherosclerosis; 1980 Nov; 37(3):333-42. PubMed ID: 7458980
[TBL] [Abstract][Full Text] [Related]
2. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
3. Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
Vessby B; Lithell H; Gustafsson IB; Borberg J
Atherosclerosis; 1979 Aug; 33(4):457-77. PubMed ID: 228684
[TBL] [Abstract][Full Text] [Related]
4. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
6. Clinical and laboratory responses to niceritrol in the treatment of hypercholesterolaemia.
Curtis LD; Reckless JP; Winder AF; Betteridge DJ
Postgrad Med J; 1988 Sep; 64(755):672-5. PubMed ID: 3075043
[TBL] [Abstract][Full Text] [Related]
7. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
[TBL] [Abstract][Full Text] [Related]
8. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
Canzler H; Bojanovski D
Artery; 1980; 8(2):171-8. PubMed ID: 7458684
[TBL] [Abstract][Full Text] [Related]
9. Effects of nicotinic acid therapy on high-density lipoprotein metabolism in type II and type IV hyperlipoproteinaemia.
Packard CJ; Stewart JM; Third JL; Morgan HG; Lawrie TD; Shepherd J
Biochim Biophys Acta; 1980 Apr; 618(1):53-62. PubMed ID: 6990991
[No Abstract] [Full Text] [Related]
10. Treatment of type III hyperlipoproteinemia with four different treatment regimens.
Hoogwerf BJ; Bantle JP; Kuba K; Frantz ID; Hunninghake DB
Atherosclerosis; 1984; 51(2-3):251-9. PubMed ID: 6588975
[TBL] [Abstract][Full Text] [Related]
11. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(12):1682-4. PubMed ID: 6686774
[TBL] [Abstract][Full Text] [Related]
12. The effect of beta-pyridylcarbinol on lipoprotein lipids in primary type IIa hyperlipoproteinemia.
Schwandt P; Weisweiler P; Neureuther G
Atherosclerosis; 1979 Sep; 34(1):35-9. PubMed ID: 227427
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of niceritrol on serum lipoprotein(a) and lipids in patients with high levels of lipoprotein(a).
Yamauchi K; Tanahashi Y; Okada M; Tsuzuki J; Sato A; Abe K; Inagaki H; Agetsuma H; Hattori R; Izawa H
Clin Ther; 1995; 17(1):52-9. PubMed ID: 7758061
[TBL] [Abstract][Full Text] [Related]
14. Serum lipoprotein composition in different types of hyperlipoproteinemia.
Carlson LA
Adv Exp Med Biol; 1975; 63():185-99. PubMed ID: 173148
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of ischemic heart disease with a hypolipoproteinemic drug pericit].
Britov AN; Shmushkovich BI; Karmanskiĭ IM
Kardiologiia; 1977 Jun; 17(6):87-91. PubMed ID: 197290
[No Abstract] [Full Text] [Related]
16. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
Gustafsson K; Kiessling H
Artery; 1981; 9(6):456-76. PubMed ID: 7337554
[TBL] [Abstract][Full Text] [Related]
17. Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population.
Jones GJ; Hewitt D; Godin GJ; Breckenridge WC; Bird J; Mishkel MA; Steiner G; Little JA
Can Med Assoc J; 1980 Jan; 122(1):37-8, 40-6. PubMed ID: 7363194
[TBL] [Abstract][Full Text] [Related]
18. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
Fellin R; Gasparotto A; Valerio G; Baiocchi MR; Padrini R; Lamon S; Vitale E; Baggio G; Crepaldi G
Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013
[TBL] [Abstract][Full Text] [Related]
19. Plasma lipoprotein changes during abstinence in chronic alcoholics.
Weidman SW; Beard JD; Sabesin SM
Atherosclerosis; 1984 Aug; 52(2):151-66. PubMed ID: 6433939
[TBL] [Abstract][Full Text] [Related]
20. Action of niceritrol (pentaerythritoltetranicotinate) on lipid accumulation in aortas of cholesterol-fed rabbits independent of contemporary reduction of serum lipids.
Brattsand R; Petersen H; Lundholm L
Atherosclerosis; 1974; 20(3):469-79. PubMed ID: 4373018
[No Abstract] [Full Text] [Related]
[Next] [New Search]
